Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mina

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Insect Biochemistry and Molecular Biology|March 29, 2023
A single point mutation in the Bemisia tabaci cytochrome-P450 CYP6CM1 causes enhanced resistance to neonicotinoidsAdam Pym, John G M Mina, Bartlomiej J Troczka, et al.
Anti-Cancer Drugs|October 17, 2015
Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatmentCarmine Carbone, Anna Tamburrino, Geny Piro, et al.
British Journal of Cancer|August 21, 2015
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patientsG Piro, S Giacopuzzi, M Bencivenga, et al.
Journal of Lipid Research|January 19, 2018
A search for ceramide binding proteins using bifunctional lipid analogs yields CERT-related protein StarD7Svenja Bockelmann, John G M Mina, Sergei Korneev, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 6, 2007
Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinomaMatteo Brunelli, Stefano Gobbo, Paolo Cossu-Rocca, et al.
Journal of Lipid Research|March 25, 2017
Switching head group selectivity in mammalian sphingolipid biosynthesis by active-site-engineering of sphingomyelin synthasesMatthijs Kol, Radhakrishnan Panatala, Mirjana Nordmann, et al.
ESMO Open|December 31, 2025
A phase II study of the AKT inhibitor TAS-117 in patients with advanced solid tumors and germline PTEN mutationsJ Ródon, H-T Arkenau, P Funchain, et al.
Journal of Lipid Research|May 12, 2016
Switching head group selectivity in mammalian sphingolipid biosynthesis by active-site engineering of sphingomyelin synthasesMatthijs Kol, Radhakrishnan Panatala, Mirjana Nordmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 8, 2007
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR studyPaolo Cossu Rocca, Matteo Brunelli, Stefano Gobbo, et al.
Cells|March 10, 2022
Illuminating Host-Parasite Interaction at the Cellular and Subcellular Levels with Infrared MicrospectroscopyHany M Elsheikha, Alaa T Al-Sandaqchi, Mohammad S R Harun, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Insect Biochemistry and Molecular Biology|March 29, 2023
A single point mutation in the Bemisia tabaci cytochrome-P450 CYP6CM1 causes enhanced resistance to neonicotinoidsAdam Pym, John G M Mina, Bartlomiej J Troczka, et al.
Anti-Cancer Drugs|October 17, 2015
Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatmentCarmine Carbone, Anna Tamburrino, Geny Piro, et al.
British Journal of Cancer|August 21, 2015
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patientsG Piro, S Giacopuzzi, M Bencivenga, et al.
Journal of Lipid Research|January 19, 2018
A search for ceramide binding proteins using bifunctional lipid analogs yields CERT-related protein StarD7Svenja Bockelmann, John G M Mina, Sergei Korneev, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 6, 2007
Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinomaMatteo Brunelli, Stefano Gobbo, Paolo Cossu-Rocca, et al.
Journal of Lipid Research|March 25, 2017
Switching head group selectivity in mammalian sphingolipid biosynthesis by active-site-engineering of sphingomyelin synthasesMatthijs Kol, Radhakrishnan Panatala, Mirjana Nordmann, et al.
ESMO Open|December 31, 2025
A phase II study of the AKT inhibitor TAS-117 in patients with advanced solid tumors and germline PTEN mutationsJ Ródon, H-T Arkenau, P Funchain, et al.
Journal of Lipid Research|May 12, 2016
Switching head group selectivity in mammalian sphingolipid biosynthesis by active-site engineering of sphingomyelin synthasesMatthijs Kol, Radhakrishnan Panatala, Mirjana Nordmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 8, 2007
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR studyPaolo Cossu Rocca, Matteo Brunelli, Stefano Gobbo, et al.
Cells|March 10, 2022
Illuminating Host-Parasite Interaction at the Cellular and Subcellular Levels with Infrared MicrospectroscopyHany M Elsheikha, Alaa T Al-Sandaqchi, Mohammad S R Harun, et al.
Pageof 9